U.S. Drug Overdose Deaths Started Declining in 2023

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, June 24, 2025 -- U.S. drug overdose deaths (DODs) started declining in 2023, with a faster decline for opioid-related versus stimulant-related DOD rates, according to a study published online June 12 in JAMA Network Open.

Lori Ann Post, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a repeated cross-sectional study of DOD rates from January 2015 to October 2024 to identify when U.S. DOD rates began to decelerate.

Between January 2015 and October 2024, 800,645 U.S. residents died of a drug overdose. The researchers observed an increase in the national DOD rate from 14.54 to 33.24 per 100,000 population from January 2015 to August 2023. The monthly DOD rate declined by −0.36 per 100,000 population from August 2023 to February 2024, accelerating to a decline of −0.84 per 100,000 population through October 2024 and reaching 24.29 per 100,000. The decline was faster for opioid-related versus stimulant-related DOD rates (−0.80 versus −0.25 per 100,000 population). The national DOD rate peaked in August 2023, while rates in the Northeast, Midwest, and South census regions peaked in October 2022; the West peaked a year later. Death rates continued to accelerate among adults aged 55 years or older by late 2023 and among American Indian or Alaska Native, Black or African American, Hispanic or Latino, and multiracial populations (0.07, 0.02, 1.70, 0.20, and 0.28 per 100,000 population, respectively), although there was a slowing in the pace of increase.

"The United States experienced a significant deceleration in DODs from 2015 through 2024," the authors write. "However, this trend was not uniform across geographic regions, demographic subpopulations, or drug types."

One author disclosed ties to Celero Systems; he and a second author disclosed ties to law companies.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords